**Trader consensus heavily favors no new COVID variant of concern before 2027, reflecting sustained low public health risk from currently circulating strains.** As of October 2026, variants such as XFG (Stratus) and BA.3.2 (Cicada) dominate monitoring lists from the WHO, CDC, and UKHSA, yet remain classified only as variants under monitoring with low additional risk. These Omicron descendants show immune escape potential and some growth in wastewater or sequencing data, but no evidence of increased severity, hospitalizations, or sustained dominance that would trigger a variant of concern designation. Broad population immunity from prior infections and updated vaccines continues to limit severe outcomes, while global surveillance detects no rapidly escalating threat. Seasonal case upticks in parts of Europe and the U.S. have stayed modest without crossing the threshold for heightened alarm. Resolution would require the WHO to formally designate a new variant of concern based on clear criteria around transmissibility, virulence, or immune evasion—developments that have not materialized in recent months and appear unlikely to accelerate dramatically within the remaining timeframe.